Role of Phosphoinositide Metabolism in Human Bronchial Smooth Muscle Contraction and in Functional Antagonism by Beta-adrenoceptor Agonists
- 1 November 1990
- journal article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 142 (5) , 1124-1128
- https://doi.org/10.1164/ajrccm/142.5.1124
Abstract
The aim of the present investigation was to study in human bronchial smooth muscle (1) the relationship between methacholine and histamine-induced inositol phosphate (IP) production and contraction, (2) the influence of increasing concentrations of methacholine and histamine on the relaxation (pD2 and Emax) by isoproterenol (functional antagonism), and (3) the relation between IP production by methacholine and histamine and the changes of pD2 and Emax values of isoproterenol-induced relaxation. Methacholine and histamine were full agonists in contracting human bronchial smooth muscle, with pD2 values of 6.01 +/- 0.18 and 6.07 +/- 0.04, respectively. With IP production, however, pD2 values of 4.90 +/- 0.06 for methacholine and 5.15 +/- 0.16 for histamine were obtained, indicating a considerable reserve of PI metabolism for contraction. With increasing concentrations of histamine and methacholine (to 1 and 0.1 mM, respectively), subsequently performed dose-relaxation curves with isoproterenol showed decreasing values of pD2 (from 8.25 +/- 0.20 to 7.28 +/- 0.28) and Emax (from 100% to 56.7 +/- 12.4%). No differences were observed between methacholine and histamine in this respect. A significant correlation was found between IP production induced by the various concentrations of methacholine and histamine and the reduction of isoproterenol pD2 and Emax values. The results strongly suggest that PI metabolism may play an important role in the reduced efficacy of beta-adrenoceptor agonists to induce bronchodilation during active and severe asthma.Keywords
This publication has 11 references indexed in Scilit:
- Airway epithelium-derived inhibitory factorTrends in Pharmacological Sciences, 1990
- Mass changes of inositol(1,4,5) trisphosphate in trachealis muscle following agonist stimulationEuropean Journal of Pharmacology, 1989
- Differential inhibitory effects of forskolin, isoproterenol, and dibutyryl cyclic adenosine monophosphate on phosphoinositide hydrolysis in canine tracheal smooth muscle.Journal of Clinical Investigation, 1988
- Muscarinic Cholinergic Inhibition of Cyclic AMP Accumulation in Airway Smooth Muscle: Role of a Pertussis Toxin-sensitive ProteinAmerican Review of Respiratory Disease, 1988
- In vivo functional antagonism between isoproterenol and bronchoconstrictants in the dogJournal of Applied Physiology, 1987
- A role for inositol 1,4,5‐trisphosphate in the initiation of agonist‐induced contractions of dog tracheal smooth muscleBritish Journal of Pharmacology, 1985
- Pharmacomechanical coupling in smooth muscle may involve phosphatidylinositol metabolism.Proceedings of the National Academy of Sciences, 1984
- Differential inhibitory effect of isoproterenol on contractions of canine airwaysJournal of Applied Physiology, 1984
- Effect of somatostatin, secretin, and glucagon on secretagogue stimulated aminopyrine uptake in isolated canine parietal cellsInflammation Research, 1983
- The Effect of Atropine Inhalation in “Irreversible” Chronic BronchitisChest, 1980